We continue to strengthen our team
At Redoxis we continue to strengthen our team and recently we had Fatemeh Ahmadi and Mario Grossi join or crew of highly competent and dedicated researchers.
Read more
Welcome Polyxeni - Director of Immunology
Introducing yet another recent addition to our team! In March, Polyxeni Mantani joined Redoxis taking on the role as Director of Immunology.
Read more
We’re hiring!
Redoxis is searching for the next colleagues to join our team. This time we are looking for a Scientist In Vivo and a Senior Scientist In Vitro. Read more using the link below and apply on our careers page. We are welcoming applications until the 14th of April.
Read more
Redoxis keeps expanding!
Recently Fredrik Berglind joined our crew of highly competent and dedicated #researchers. We are very happy to have him on board and with his background and expertise in #neurodegenerative diseases he will complement and strengthen our #service capacities for continuous strive for excellence!
Read more
SmiLe Incubator 15 year celebration!
Congratulations SmiLe Incubator and thanks for the support during the years! Being part of the incubator setting with support, network and availability of laboratory equipment was crucial during the early years of Redoxis as well as now as an alumni member.
Read more
Half time seminar
Yesterday, Alex Moreno, who is pursuing his industrial PhD at Redoxis in collaboration with Karolinska Institutet, held his half time defense in Stockholm.
Read more
Good luck Francesco!
It is equally important to acknowledge a coworker leaving as it is celebrating new colleagues joining our team.
Read more
Christmas meeting & dinner
Yesterday we had our last meeting before the holidays to sum up this fantastic year, followed by a lovely dinner in Malmö.
Read more
SwedenBIO summit 2022
Last week, Malin Hultqvist Hopkins and Nina Woodworth attended the SwedenBIO summit 2022 in Stockholm. The annual event where this year, lifescience leaders were gathered to discuss around financing, recruitment and IP strategy, share latest news and network.
Read more
The team is expanding
Better late than never, we would like to present two of our latest additions to the Redoxis team! Before the summer we had Elin Benatti and Kedir Hussen Hamza join or crew of highly competent and dedicated researchers.
Read more
Redox Alterations and Cellular Responses
This week, our Linda Reimer Rasmusson is attending the FEBS Advanced Lecture Course on the topic "Redox Alterations and Cellular Responses" sponsored by Redoxis AB and taking place on the beautiful Spetses Island in Greece.
Read more
New model description available
We recently released a new model description of our DSS induced Colitis model in mice. This model is a good tool for investigation of effects of novel therapies for Chron Disease and Ulcerative Colitis. DSS in drinking water induces intestinal inflammation allowing pro inflammatory intestinal content into the underlying tissue.
Read more
Redoxis signs license agreement with VivoLogica
Redoxis AB recently signed a license agreement with VivoLogica for use of their software platform for in vivo study management. This is an important step in our journey and aim to provide highest quality data in all our preclinical projects. We are looking forward to our continued collaboration with the VivoLogica team.
Read more
Redoxis and Amarna Therapeutics receive EUREKA Eurostars grant for project ALPHAVAC
We are happy to announce that Redoxis, together with our Dutch partner Amarna Therapeutics has been awarded a €0,8 million grant from EUREKA Eurostars to establish a screening platform for the advancement of potential first-in-class gene therapy for ALS and other neurodegenerative diseases using Amarna´s proprietary SVec viral vector platform.
Read more
Redoxis in collaborative project to study inflammation in vascular disease
We are happy to announce that Redoxis AB is a partner in a research project called “Targeting he melanocortin system as a novel strategy to reduce inflammation during vascular disease” led by Senior Lecturer Liza Ljungberg, School of Medical Sciences at Örebro University. The project was
funded by a research grant of SEK 4 million from The Knowledge Foundation, funding research and competence development at Swedish universities. Redoxis will contribute to the project, that is planned to start 1st of July 2021, with expertise in preclinical drug development and efficacy
assessment in both disease models and functional assays. “Participating in this project is in line with Redoxis aim to continuously expand competence area, implement new clinically relevant models and stay closely connected with academic research in our quest to be the best contract research
organization in preclinical inflammatory research” says Malin Hultqvist Hopkins, CEO of Redoxis AB The project is a collaboration between Örebro University, SynAct Pharma AB and Redoxis AB.
Read more
Redoxis is once again accredited for CIR (French Research Tax Reduction)
Redoxis has been granted approval for the French research tax credit (CIR) for 2021, 2022 and 2023 from the French Ministry of Higher Education and R...
Read more
We are increasing our In Vitro service capacity
This week we are welcoming Linda Reimer Rasmusson back to Redoxis. Linda started her carreer at Redoxis and is now returning to strengthen our In Vit...
Read more
Welcome Tekla!
The newest addition to our team is Tekla Franzén. Tekla is a trained animal technician and held her the most recent position at the Lund University a...
Read more
Seasons greetings
...
Read more
Are you our new collegue?
We have an open position for a laboratory technician with focus on in vivo work (försöksdjurstekniker). Read more here or contact us directly for mor...
Read more
Models of cytokine release for evaluation of efficacy in acute innate inflammatory responses
Recently, much attention has been given the role of proinflammatory cytokines in pathology of COVID-19. Massive release of cytokines, cytokine storm,...
Read more
Redoxis announces approved Eurostars funding for project E!114520 - ACTION
We are very happy to announce that our joint project application E!114520 ACTION has been approved as a Eurostars labelled project and funding by the...
Read more
We are growing even stronger
A warm welcome to Jens Holmberg, PhD, the latest addition to our team. Jens has a background in preclinical inflammation research with extensive expe...
Read more
Cell based 3D immunology assays: mimicking in vivo structures in models of inflammation
We are continuously adding more assays and models to our portfolio while also actively improving our current models. In collaboration with Cellevate ...
Read more
Redoxis AB signs a 3-year agreement with Taconic Biosciences, Inc.
Redoxis AB has signed an agreement with Taconic Biosciences, Inc for service of characterization of cellular composition of Taconic’s humanized immun...
Read more
Registered US trademark
As of beginning of March, Redoxis is now a registered trademark in the US. Redoxis has previously been a registered trademark in Sweden and European ...
Read more
We are fully operational
The current Covid-19 situation is clearly affecting all of us but Redoxis CRO services are still fully operational. In addition to our already valida...
Read more
Redoxis´ first PhD student
Alex Moreno joined our company fall of 2018 as an early stage researcher through the European Training Network COSMIC, funded from the European Union...
Read more
Master project available
Successful translation of in vitro results to in vivo proof of concept data is essential in early drug development. Traditionally, in vitro models ha...
Read more
New lab celebration
In the end of December, Redoxis moved into new lab facilities within Medicon Village. With increased lab space and more offices, the new facilities a...
Read more
NeutroCure kick-off meeting
Last week, we successfully kicked off the Horizon 2020 funded FETOPEN program NeutroCure (agreement No 861878). The consortium, with partners from Fr...
Read more
Eurostars Butterfly project meeting
The H2020 funded Eurostars project BUTTERFLY (E! 12979) is well off and in full speed ahead. This week we had a joint meeting with the collaborating ...
Read more
BioFit 2019
Next week, our Senior scientist PhD Francesco Bez will be at the BioFit meeting in Marseille. Francesco is specialising in neurodegenerative diseases...
Read more
Educational day with Redoxis founders
We started off this week with an educational day including presentations from Professor Rikard Holmdahl and Peter Olofsson on Redoxis background and ...
Read more
Standardized preparation of emulsions results in less variation in vivo - a collaboration with BTB Emulsions
As part of our internal efforts to standardize in vivo models to decrease inter-experimental variations, we have evaluated the POWER emulsion prepara...
Read more
Pharma Outsourcing 2019
Come and meet with us during the annual Pharma outsourcing meeting in Stockholm taking place the 10th of December. The meeting includes both presenta...
Read more
Bio-Europe 2019
This week we are excited to attend the 25th edition of Bio-Europe. Redoxis is represented by CEO Malin Hultqvist Hopkins and we are looking forward to...
Read more
Publication on effects of ROS on handling of necrotic cells
Recently, our manuscript "NOX2 mediates quiescent handling of dead cell remnants in phagocytes" was published in Redox Biology. The paper describes th...
Read more
Redoxis receives Horizon 2020 grant
The FET Open Horizon 2020 project under acronym NeutroCure, in which Redoxis is one of the partners, has been granted by the EU commission. The projec...
Read more
BioPharm America
During September, CEO Malin Hultqvist Hopkins attended the BioPharm America partnering meeting in Boston, MA. This was the first meeting attended by R...
Read more
BioEurope spring 2019
We are in full preparation for the BioEurope spring in Wienna taking place 25th to 27th March. We will be happy to catch up on your needs for preclini...
Read more
Open position
We are looking for a new member of our in vivo team. Preferably you have a background with preclinical inflammation models and contract research. For ...
Read more
Meet us att BioEurope
Redoxis will be represented at BioEurope taking place in Copenhagen 5-7th of November. Come meet us at our stand (#110) or book a one-to-one meeting t...
Read more
Redoxis receives CIR (French Research Tax Credit) accreditation
Redoxis has been granted approval for the French research tax credit (CIR) for 2018, 2019 and 2020 from the French Ministry of Higher Education and Re...
Read more
Nordic life science days 2018
Next week Malin Hultqvist Hopkins (CEO) will be at the Nordic Life Science days (NLS days) in Stockholm. Get in touch if you are attending and would l...
Read more
Brain Gain
Redoxis is today at Brain Gain Sweden! Francesco Bez is a speaker during the innovation panel (aging brain disorders) presenting our latest developmen...
Read more
Meet us at the 11th FENS forum of Neuroscience
Francesco Bez will attend the FENS forum of neuroscience taking place in Berlin on the 7-11 of July. We continuously add more models to our portfolio ...
Read more
Redoxis annual summer meeting
Yesterday, Redoxis had its annual summer meeting with many fruitful discussions followed by a tough contest (you might see who was on the winning team...
Read more
Society for free radical research international biannual meeting
As part of the RISE project REDOXIT (Marie Sklodowska-Curie Action) we are present at the SFRRI meeting in Lisbon next week. By attending this meeting...
Read more
Meet us at the Global Discovery to Development Innovation Forum
Francesco Bez will be present at the 11th Global Discovery to Development Innovation Forum (GDDIF) taking place in Amsterdam 16-17th of May. We contin...
Read more
Magnetic resonance imaging in animal models
Established under the Eurostars E9215 (IMAID) program, Redoxis can now offer magnetic resonance imaging services in animal models. Redoxis offer, toge...
Read more
Meet us at BioEurope Spring
Malin H Hopkins (CEO) will be present at BioEurope Spring taking place in Amsterdam 12-14th of March. We continuously add more models to our portfolio...
Read more
NEW - In vivo models of Psoriasis and Psoriatic arthritis
Redoxis is now proud to offer models of Psoriasis (IMQ model) and Psoriatic Arthritis (MiP) model. Psoriasis is a common autoimmune disease affecting ...
Read more
Newest member of our team - Frida
We are, since december, happy to have Frida on our team of researchers. Frida just finished her master in molecular biology at the University of Lund ...
Read more
Applications invited
Applications are invited for 14 ESRs (Early Stage Researchers) funded by the Marie-Sklodowska-Curie Innovative Training Network COSMIC (Combatting dis...
Read more
Redoxis a part of COSMIC
As of the first of January 2018 Redoxis is a part of the international consortium COSMIC. COSMIC systems medicine training and research programme kic...
Read more
Meet us at BioEurope 6-8 November, Berlin
We will be at the BioEurope meeting in Berlin from 6-8 of November. Take the opportunity to meet with us for a presentation of our services and models...
Read more
Want to join our team?
We are looking to expand our team with a person experienced in laboratory work and preclinical in vivo models of inflammatory diseases. More informati...
Read more
NEW - LPS induced acute inflammation in mice
We are continuously adding new, well characterised models to our portfolio and the latest is the LPS induced acute inflammation model in mice. Mice ar...
Read more
Nordic Life Science days 2017
Redoxis will be represented by Sebastian Hansson at the Nordic Life Science (NLS) days in Malmö/Copenhagen the 12th-14th September. Sebastian will be ...
Read more
Meet Sebastian
Since June this year, we are happy to have Sebastian Hansson, Business Development Manager, joint our team. Sebastian will strengthen our competence w...
Read more
We are welcoming Francesco Bez to our team
Starting today, we are happy to have Francesco Bez (PhD) joining our team. Francesco holds a PhD in Neuroscience and is an expert in in vivo models of...
Read more
Meet us at the Future of Swedish and Danish life science days
The future of Swedish and Danish life science days will be taking place the 30th of March at Medicon village in Lund. Redoxis will be represented with...
Read more
BioEurope Spring 2017
Redoxis attended the BioEurope spring partnering meeting in Barcelona 20-22 March. During this successful event we enjoyed meetings with new partners ...
Read more
5-year celebration with Medicon Village
Friday the 20th of January, Medicon Village hosted a large event to celebrate their first 5-years. Their success have been enormous and plans for the ...
Read more
Published paper on effects of cytokines using our rat ex vivo model
The electronic version of our manuscript "Cytokine correlation analysis based on drug perturbation" was recently accepted published after acceptance i...
Read more
Meet us at BioEurope in Cologne 7-9 Nov
Redoxis will, as a part of a delegation of innovative life science companies from Skåne, together with Invest in Skåne participate in the partnering m...
Read more
Pristane induced arthritis (PIA) in focus
Innovative Medicines Initiative BTCure, in which Redoxis is a partner, has combined experience from laboratories worldwide to establish standardised p...
Read more
New CEO
Since May 1st Malin Hultqvist Hopkins, former CSO, is appointed CEO of Redoxis. This change is in line with Redoxis continuous ambition to be a focuse...
Read more
BioEurope is finally in Stockholm
Since BioEurope is one of the main events for partnering and drug development collaborations, Redoxis is during 4-6 April in Stockholm attending the B...
Read more
We are expanding our in vitro/ex vivo analysis capacity
At Redoxis, we have a fully equipped lab for work with both primary cells and cell lines. We also hava fully equipped laboratory for post experiment f...
Read more
Pharmaoutsourcing in Stockholm 9th December
In the 9th of December we will attend the PHARMA OUTSOURCING meeting in Stockholm- This is a new annual international partnering meeting for Investme...
Read more
NEURINOX gathers top researchers, patients and industry in an international symposium on innovative concepts for treating neurodegenerative diseases
Neurodegeneration leads to chronic debilitating diseases, including age-related syndromes like Alzheimer's and Parkinson's diseases and disorders affe...
Read more
Meeting partners and NLS days in Stockholm 9-10 september
Attending one of the largest partnering event in Life Science, these days taking place in Stockholm 9-10 September- 2015. This will be an event not on...
Read more
Tax reduction eligibility for Redoxis services
Redoxis has been approved by the French authorities "Ministère chargé de l'Enseignement supérieur et de la Recherche" eligible for tax reduction for s...
Read more
RISE - European collaboration with Aston University and University of Erlangen
This month we started the RISE project REDOXIT for Research and Innovation Staff Exchange (RISE) as a collaborative project with Aston University (Bir...